Rare diseases
Investigational molecules
Locations
Back to Austria838 clinical trials in Vienna, Austria across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis
AustriaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
AustriaStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
AustriaStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
AustriaStudy on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen
AustriaMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
AustriaA Phase 3 Study of Once‑Daily Treprostinil Palmitil Inhalation Powder for Adults with Pulmonary Arterial Hypertension
AustriaStudy of dapirolizumab pegol placental transfer to infants in pregnant women with active systemic lupus erythematosus (drug combination)
AustriaEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
AustriaA Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer
AustriaLong‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma
AustriaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
AustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including pancreatic ductal adenocarcinoma, gastric cancer, and non-small cell lung cancer. Studies evaluating new therapeutic approaches for breast cancer and multiple myeloma are also underway.
Research includes evaluation of novel drug combinations and immunotherapy approaches for improved patient outcomes.
Investigations into major depression and its treatment mechanisms, including studies on dopamine synthesis and antidepressant effectiveness. Research examines innovative therapeutic approaches using ketamine and other compounds.
Focus on understanding brain activation patterns and treatment responses in psychiatric conditions.
Research on plaque psoriasis, rheumatic diseases, and Sjögren's syndrome. Studies evaluate new biological therapies and treatment approaches for chronic inflammatory conditions.
Emphasis on developing targeted therapies for improved disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
